The American Diabetes Association (ADA) established guidelines for HbA1c monitoring to reduce the risk of adverse events in patients with type 2 diabetes mellitus (T2DM). Despite the availability of HbA1c point-of-care tests (POCT) at a federally qualified health center (FQHC) in Oregon (OR), where this quality improvement (QI) project was conducted, nearly one-third of the patients with diabetes poor control had no HbA1c in the year prior. This project aims to increase staff knowledge and use of evidence-based diabetic care practices and to identify the utility of HbA1c POCT to increase HbA1c monitoring at an FQHC in a rural county in Oregon (OR).
